{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P05231",
      "entity_text" : "IL-6",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0460" ],
      "CellLine" : [ "cellosaurus:CVCL_W770" ],
      "Cellular_component" : [ "uniprot:SL-0039" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "Species" : [ "taxonomy:10090" ],
      "CellType" : [ "cl:CL:0000540" ]
    }
  },
  "verbose_text" : "The PPARgamma antagonist GW9662 (i.e., in the GW9662 treated group), showed a significant reversal in only the TNF-alpha level, but not in IL-6 and IL-1beta levels compared with the atorvastatin treated group.",
  "reading_complete" : "2020-08-09T19:28:30Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-09T19:26:41Z",
  "trigger" : "levels",
  "evidence" : [ "IL-6 and IL-1beta levels" ],
  "pmc_id" : "7232118",
  "score" : 0
}